Adiposity and cancer at major anatomical sites: Umbrella review of the literature

BMJ (Online)

Volumn 356, Issue , 2017, Pages

  Kyrgiou, Maria ^a,b   Kalliala, Ilkka ^a   Markozannes, Georgios ^c   Gunter, Marc J ^d   Paraskevaidis, Evangelos ^e   Gabra, Hani ^a,b   Martin Hirsch, Pierre ^f,g   Tsilidis, Konstantinos K ^a,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c UNIVERSITY OF IOANNINA   (Greece)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e UNIVERSITY OF IOANNINA   (Greece)

^f LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIARY TRACT CANCER; BODY MASS; BREAST CANCER; CANCER RISK; CARDIA; COLON CANCER; DISEASE ASSOCIATION; DYING; ENDOMETRIUM CANCER; ESOPHAGEAL ADENOCARCINOMA; GALLBLADDER CANCER; HORMONE SUBSTITUTION; HUMAN; KIDNEY CANCER; MALIGNANT NEOPLASM; MORTALITY RISK; MULTIPLE MYELOMA; OBESITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVARY CANCER; PANCREAS CANCER; POSTMENOPAUSE; PREMENOPAUSE; PUBLIC HEALTH PROBLEM; RECTUM CANCER; REVIEW; SENSITIVITY ANALYSIS; STOMACH CANCER; SYSTEMATIC REVIEW (TOPIC); WAIST HIP RATIO; WEIGHT GAIN; META ANALYSIS (TOPIC); NEOPLASMS; PATHOPHYSIOLOGY;

ADIPOSITY; HUMANS; META-ANALYSIS AS TOPIC; NEOPLASMS; OBSERVATIONAL STUDIES AS TOPIC;

EID: 85014244087     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.j477     Document Type: Review

References (108)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.Estimates of worldwide burden of cancer in 2008: GLOBOCAN2008. Int J Cancer 2010;127:2893-917. doi:10.1002/ijc.25516.
2. Dixon JB. The effect of obesity on health outcomes. Mol CellEndocrinol 2010;316:104-8. doi:10.1016/j.mce.2009.07.008.
3. Stevens GA, Singh GM, Lu Y, et al. Global Burden of Metabolic RiskFactors of Chronic Diseases Collaborating Group (Body Mass Index).National, regional, and global trends in adult overweight and obesityprevalences. Popul Health Metr 2012;10:22.doi:10.1186/1478-7954-10-22.
4. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-massindex in 200 countries from 1975 to 2014: a pooled analysis of 1698population-based measurement studies with 19-2 millionparticipants. Lancet 2016;387:1377-96. doi:10.1016/S0140-6736(16)30054-X.
5. Ng M, Fleming T, Robinson M, et al. Global, regional, and nationalprevalence of overweight and obesity in children and adults during1980-2013: a systematic analysis for the Global Burden of DiseaseStudy 2013. Lancet 2014;384:766-81. doi:10.1016/S0140-6736(14)60460-8.
6. Marmot M, Atinmo T, Byers T, et al. Food, nutrition, physical activity, and the prevention of cancer: a global perspective.World CancerResearch Fund/American Institute for Cancer Research, 2007.
7. Ioannidis JP. Why most discovered true associations are inflated.Epidemiology 2008;19:640-8. doi:10.1097/EDE.0b013e31818131e7.
8. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124. doi:10.1371/journal.pmed.0020124.
9. Dwan K, Gamble C, Williamson PR, Kirkham JJ, Reporting Bias G.Reporting Bias Group. Systematic review of the empirical evidence ofstudy publication bias and outcome reporting bias-an updatedreview. PLoS One 2013;8:e66844. doi:10.1371/journal.pone.0066844.
10. Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ.False-positive results in cancer epidemiology: a plea forepistemological modesty. J Natl Cancer Inst 2008;100:988-95.doi:10.1093/jnci/djn191.
11. Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2diabetes and cancer: umbrella review of meta-analyses ofobservational studies. BMJ 2015;350:g7607. doi:10.1136/bmj.g7607.
12. Ioannidis JP. Integration of evidence from multiple meta-analyses: aprimer on umbrella reviews, treatment networks and multipletreatments meta-analyses. CMAJ 2009;181:488-93. doi:10.1503/cmaj.081086.
13. Markozannes G, Tzoulaki I, Karli D, et al. Diet, body size, physicalactivity and risk of prostate cancer: An umbrella review of theevidence. Eur J Cancer 2016;69:61-9. doi:10.1016/j.ejca.2016.09.026.
14. Belbasis L, Savvidou MD, Kanu C, Evangelou E, Tzoulaki I. Birth weightin relation to health and disease in later life: an umbrella review ofsystematic reviews and meta-analyses. BMC Med 2016;14:147.doi:10.1186/s12916-016-0692-5.
15. Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP.Environmental risk factors and Parkinson's disease: An umbrellareview of meta-analyses. Parkinsonism Relat Disord 2016;23:1-9.doi:10.1016/j.parkreldis.2015.12.008.
16. Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I.Environmental risk factors and multiple sclerosis: an umbrella reviewof systematic reviews and meta-analyses. Lancet Neurol 2015;14:263-73. doi:10.1016/S1474-4422(14)70267-4.
17. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D andmultiple health outcomes: umbrella review of systematic reviews andmeta-analyses of observational studies andrandomised trials. BMJ2014;348:g2035. doi:10.1136/bmj.g203518
18. Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JP, Evangelou E.Systematic evaluation of the associations between environmental riskfactors and dementia: An umbrella review of systematic reviews andmeta-analyses. Alzheimers Dement 2016;S1552-5260(16)32853-9.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control ClinTrials 1986;7:177-88. doi:10.1016/0197-2456(86)90046-2.
20. Cochran WG. The combination of estimates from differentexperiments. Biometrics 1954;10:101-29doi:10.2307/3001666.
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuringinconsistency in meta-analyses. BMJ 2003;327:557-60. doi:10.1136/bmj.327.7414.557.
22. Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty inheterogeneity estimates in meta-analyses. BMJ 2007;335:914-6.doi:10.1136/bmj.39343.408449.80.
23. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effectsmeta-analyses. BMJ 2011;342:d549. doi:10.1136/bmj.d549.
24. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations forexamining and interpreting funnel plot asymmetry in meta-analysesof randomised controlled trials. BMJ 2011;343:d4002. doi:10.1136/bmj.d4002.
25. Ioannidis JP, Trikalinos TA. An exploratory test for an excess ofsignificant findings. Clin Trials 2007;4:245-53.doi:10.1177/1740774507079441.
26. Tsilidis KK, Panagiotou OA, Sena ES, et al. Evaluation of excesssignificance bias in animal studies of neurological diseases. PLoS Biol2013;11:e1001609. doi:10.1371/journal.pbio.1001609.
27. Tsilidis KK, Papatheodorou SI, Evangelou E, Ioannidis JP. Evaluation ofexcess statistical significance in meta-analyses of 98 biomarkerassociations with cancer risk. J Natl Cancer Inst 2012;104:1867-78.doi:10.1093/jnci/djs437.
28. Ioannidis JPA. Clarifications on the application and interpretation ofthe test for excess significance and its extensions. J Math Psychol2013;57:184-7doi:10.1016/j.jmp.2013.03.002.
29. Salanti G, Ioannidis JP. Synthesis of observational studies shouldconsider credibility ceilings. J Clin Epidemiol 2009;62:115-22.doi:10.1016/j.jclinepi.2008.05.014.
30. Papatheodorou SI, Tsilidis KK, Evangelou E, Ioannidis JP. Application ofcredibility ceilings probes the robustness of meta-analyses ofbiomarkers and cancer risk. J Clin Epidemiol 2015;68:163-74.doi:10.1016/j.jclinepi.2014.09.004.
31. Ioannidis JP, Tarone R, McLaughlin JK. The false-positive tofalse-negative ratio in epidemiologic studies. Epidemiology2011;22:450-6. doi:10.1097/EDE.0b013e31821b506e.
32. Sterne JA, Davey Smith G. Sifting the evidence-what's wrong withsignificance tests?BMJ 2001;322:226-31. doi:10.1136/bmj.322.7280.226.
33. Johnson VE. Revised standards for statistical evidence. Proc Natl AcadSci USA 2013;110:19313-7. doi:10.1073/pnas.1313476110.
34. StataCorp. Stata Statistical Software: Release 13.StataCorp LP, 2013.
35. Alsamarrai A, Das SL, Windsor JA, Petrov MS. Factors that affect risk forpancreatic disease in the general population: a systematic review andmeta-analysis of prospective cohort studies. Clin GastroenterolHepatol 2014;12:1635-44.e5, quiz e103. doi:10.1016/j.cgh.2014.01.038.
36. Amadou A, Ferrari P, Muwonge R, et al. Overweight, obesity and risk ofpremenopausal breast cancer according to ethnicity: a systematicreview and dose-response meta-analysis. Obes Rev 2013;14:665-78.doi:10.1111/obr.12028.
37. Aune D, Greenwood DC, Chan DS, et al. Body mass index, abdominalfatness and pancreatic cancer risk: a systematic review and non-lineardose-response meta-analysis of prospective studies. Ann Oncol2012;23:843-52. doi:10.1093/annonc/mdr398.
38. Aune D, Navarro Rosenblatt DA, Chan DS, et al. Anthropometricfactors and ovarian cancer risk: a systematic review and nonlineardose-response meta-analysis of prospective studies. Int J Cancer2015;136:1888-98. doi:10.1002/ijc.29207.
39. Aune D, Navarro Rosenblatt DA, Chan DS, et al. Anthropometricfactors and endometrial cancer risk: a systematic review anddose-response meta-analysis of prospective studies. Ann Oncol2015;26:1635-48. doi:10.1093/annonc/mdv142.
40. Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, andbiochemical recurrence: a systematic review and meta-analysis.Cancer Prev Res (Phila) 2011;4:486-501. doi:10.1158/1940-6207.CAPR-10-0229.
41. Casagrande DS, Rosa DD, Umpierre D, Sarmento RA, Rodrigues CG, Schaan BD. Incidence of cancer following bariatric surgery: systematicreview and meta-analysis. Obes Surg 2014;24:1499-509.doi:10.1007/s11695-014-1276-0.
42. Castillo JJ, Ingham RR, Reagan JL, Furman M, Dalia S, Mitri J. Obesity isassociated with increased relative risk of diffuse large B-celllymphoma: a meta-analysis of observational studies. Clin LymphomaMyeloma Leuk 2014;14:122-30. doi:10.1016/j.clml.2013.10.005.
43. Castillo JJ, Reagan JL, Ingham RR, et al. Obesity but not overweightincreases the incidence and mortality of leukemia in adults: ameta-analysis of prospective cohort studies. Leuk Res 2012;36:868-75. doi:10.1016/j.leukres.2011.12.020.
44. Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the riskof primary liver cancer: an updated meta-analysis of prospectivestudies. Eur J Cancer 2012;48:2137-45. doi:10.1016/j.ejca.2012.02.063.
45. Connolly BS, Barnett C, Vogt KN, Li T, Stone J, Boyd NF. A meta-analysisof published literature on waist-to-hip ratio and risk of breast cancer.Nutr Cancer 2002;44:127-38. doi:10.1207/S15327914NC4402-02.
46. Discacciati A, Orsini N, Wolk A. Body mass index and incidence oflocalized and advanced prostate cancer-a dose-responsemeta-analysis of prospective studies. Ann Oncol 2012;23:1665-71.doi:10.1093/annonc/mdr603.
47. Harriss DJ, Atkinson G, George K, et al. C-CLEAR group. Lifestyle factorsand colorectal cancer risk (1): systematic review and meta-analysis ofassociations with body mass index. Colorectal Dis 2009;11:547-63.doi:10.1111/j.1463-1318.2009.01766.x.
48. Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk:a systematic review. Obes Rev 2003;4:157-73.doi:10.1046/j.1467-789X.2003.00108.x.
49. Keum N, Greenwood DC, Lee DH, et al. Adult weight gain andadiposity-related cancers: a dose-response meta-analysis ofprospective observational studies. J Natl Cancer Inst2015;107doi:10.1093/jnci/djv088.
50. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: ameta-analysis of prospective studies. Am J Clin Nutr 2007;86:556-65.
51. Larsson SC, Wolk A. Obesity and risk of non-Hodgkin's lymphoma: ameta-analysis. Int J Cancer 2007;121:1564-70. doi:10.1002/ijc.22762.
52. Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: ameta-analysis. Br J Cancer 2007;96:1457-61.
53. Larsson SC, Wolk A. Body mass index and risk of non-Hodgkin's andHodgkin's lymphoma: a meta-analysis of prospective studies. Eur JCancer 2011;47:2422-30. doi:10.1016/j.ejca.2011.06.029.
54. Li JS, Han TJ, Jing N, et al. Obesity and the risk of cholangiocarcinoma:a meta-analysis. Tumour Biol 2014;35:6831-8. doi:10.1007/s13277-014-1939-4.
55. Lin XJ, Wang CP, Liu XD, et al. Body mass index and risk of gastriccancer: a meta-analysis. Jpn J Clin Oncol 2014;44:783-91.doi:10.1093/jjco/hyu082.
56. Ma J, Huang M, Wang L, Ye W, Tong Y, Wang H. Obesity and risk ofthyroid cancer: evidence from a meta-analysis of 21 observationalstudies. Med Sci Monit 2015;21:283-91. doi:10.12659/MSM.892035.
57. Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: asystematic review of prospective studies. PLoS One 2013;8:e53916.doi:10.1371/journal.pone.0053916.
58. MacInnis RJ, English DR. Body size and composition and prostatecancer risk: systematic review and meta-regression analysis. CancerCauses Control 2006;17:989-1003. doi:10.1007/s10552-006-0049-z.
59. Moghaddam AA, Woodward M, Huxley R. Obesity and risk ofcolorectal cancer: a meta-analysis of 31 studies with 70, 000 events.Cancer Epidemiol Biomarkers Prev 2007;16:2533-47.doi:10.1158/1055-9965.EPI-07-0708.
60. Park M, Song DY, Je Y, Lee JE. Body mass index and biliary tractdisease: a systematic review and meta-analysis of prospectivestudies. Prev Med 2014;65:13-22. doi:10.1016/j.ypmed.2014.03.027.
61. Poorolajal J, Jenabi E. The association between BMI and cervicalcancer risk: a meta-analysis. Eur J Cancer Prev 2016;25:232-8.doi:10.1097/CEJ.0000000000000164.
62. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-massindex and incidence of cancer: a systematic review and meta-analysisof prospective observational studies. Lancet 2008;371:569-78.doi:10.1016/S0140-6736(08)60269-X.
63. Schlesinger S, Lieb W, Koch M, et al. Body weight gain and risk ofcolorectal cancer: a systematic review and meta-analysis ofobservational studies. Obes Rev 2015;16:607-19. doi:10.1111/obr.12286.
64. Sergentanis TN, Antoniadis AG, Gogas HJ, et al. Obesity and risk ofmalignant melanoma: a meta-analysis of cohort and case-controlstudies. Eur J Cancer 2013;49:642-57. doi:10.1016/j.ejca.2012.08.028.
65. Shao C, Bai LP, Qi ZY, Hui GZ, Wang Z. Overweight, obesity andmeningioma risk: a meta-analysis. PLoS One 2014;9:e90167.doi:10.1371/journal.pone.0090167.
66. Singh S, Sharma AN, Murad MH, et al. Central adiposity is associatedwith increased risk of esophageal inflammation, metaplasia, andadenocarcinoma: a systematic review and meta-analysis. ClinGastroenterol Hepatol 2013;11:1399-1412.e7. doi:10.1016/j.cgh.2013.05.009.
67. Sun JW, Zhao LG, Yang Y, Ma X, Wang YY, Xiang YB. Obesity and risk ofbladder cancer: a dose-response meta-analysis of 15 cohort studies.PLoS One 2015;10:e0119313. doi:10.1371/journal.pone.0119313.
68. Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence ofbreast cancer defined by estrogen and progesterone receptorstatus-a meta-analysis. Int J Cancer 2009;124:698-712. doi:10.1002/ijc.23943.
69. Upala S, Anawin S. Bariatric surgery and risk of postoperativeendometrial cancer: a systematic review and meta-analysis. SurgObes Relat Dis 2015;11:949-55. doi:10.1016/j.soard.2014.09.024.
70. Wallin A, Larsson SC. Body mass index and risk of multiple myeloma:a meta-analysis of prospective studies. Eur J Cancer 2011;47:1606-15.doi:10.1016/j.ejca.2011.01.020.
71. Wang F, Xu Y. Body mass index and risk of renal cell cancer: adose-response meta-analysis of published cohort studies. Int J Cancer2014;135:1673-86. doi:10.1002/ijc.28813.
72. Wang Y, Wang B, Shen F, Fan J, Cao H. Body mass index and risk ofprimary liver cancer: a meta-analysis of prospective studies.Oncologist 2012;17:1461-8. doi:10.1634/theoncologist.2012-0066.
73. Yang XW, Li PZ, Zhu LY, Zhu S. Effects of bariatric surgery on incidenceof obesity-related cancers: a meta-analysis. Med Sci Monit2015;21:1350-7. doi:10.12659/MSM.893553.
74. Yang Y, Dong J, Sun K, et al. Obesity and incidence of lung cancer: ameta-analysis. Int J Cancer 2013;132:1162-9. doi:10.1002/ijc.27719.
75. Zhang X, Zhou G, Sun B, et al. Impact of obesity upon prostatecancer-associated mortality: A meta-analysis of 17 cohort studies.Oncol Lett 2015;9:1307-12.
76. Zhang Y, Liu H, Yang S, Zhang J, Qian L, Chen X. Overweight, obesityand endometrial cancer risk: results from a systematic review andmeta-analysis. Int J Biol Markers 2014;29:e21-9. doi:10.5301/jbm.5000047.
77. Poorolajal J, Jenabi E, Masoumi SZ. Body mass index effects on risk ofovarian cancer: a meta-analysis. Asian Pac J Cancer Prev2014;15:7665-71. doi:10.7314/APJCP.2014.15.18.7665.
78. Cheraghi Z, Poorolajal J, Hashem T, Esmailnasab N, Doosti Irani A.Effect of body mass index on breast cancer during premenopausaland postmenopausal periods: a meta-analysis. PLoS One2012;7:e51446. doi:10.1371/journal.pone.0051446.
79. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Bodymass index, hormone replacement therapy, and endometrial cancerrisk: a meta-analysis. Cancer Epidemiol Biomarkers Prev2010;19:3119-30. doi:10.1158/1055-9965.EPI-10-0832.
80. Robsahm TE, Aagnes B, Hjartåker A, Langseth H, Bray FI, Larsen IK.Body mass index, physical activity, and colorectal cancer byanatomical subsites: a systematic review and meta-analysis of cohortstudies. Eur J Cancer Prev 2013;22:492-505. doi:10.1097/CEJ.0b013e328360f434.
81. Turati F, Tramacere I, La Vecchia C, Negri E. A meta-analysis of bodymass index and esophageal and gastric cardia adenocarcinoma. AnnOncol 2013;24:609-17. doi:10.1093/annonc/mds244.
82. Larsson SC, Wolk A. Overweight and obesity and incidence ofleukemia: a meta-analysis of cohort studies. Int J Cancer2008;122:1418-21. doi:10.1002/ijc.23176.
83. Pierobon M, Frankenfeld CL. Obesity as a risk factor for triple-negativebreast cancers: a systematic review and meta-analysis. Breast CancerRes Treat 2013;137:307-14. doi:10.1007/s10549-012-2339-3.
84. Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, StraifK. International Agency for Research on Cancer Handbook WorkingGroup. Body Fatness and Cancer-Viewpoint of the IARC WorkingGroup. N Engl J Med 2016;375:794-8. doi:10.1056/NEJMsr1606602.
85. World Cancer Research Fund CUP. http://www.wcrf.org/int/research-we-fund/continuous-update-project-cup.
86. Guyatt GH, Oxman AD, Vist GE, et al. GRADE Working Group. GRADE:an emerging consensus on rating quality of evidence and strength ofrecommendations. BMJ 2008;336:924-6. doi:10.1136/bmj.39489.470347.AD.
87. World Cancer Research Fund International/American Institute forCancer Research Continuous Update Project Report. Diet, Nutrition, Physical Activity, and Endometrial Cancer. 2013; Available at: http://www.wcrf.org/sites/default/files/Endometrial-Cancer-2013-Report.pdf.
88. McCullough ML, Patel AV, Patel R, et al. Body mass and endometrialcancer risk by hormone replacement therapy and cancer subtype.Cancer Epidemiol Biomarkers Prev 2008;17:73-9. doi:10.1158/1055-9965.EPI-07-2567.
89. Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancerrisk: findings from the European Prospective Investigation into CancerAnd Nutrition (EPIC). Int J Cancer 2004;111:762-71. doi:10.1002/ijc.20315.
90. White KK, Park SY, Kolonel LN, Henderson BE, Wilkens LR. Body sizeand breast cancer risk: the Multiethnic Cohort. Int J Cancer2012;131:E705-16. doi:10.1002/ijc.27373.
91. World Cancer Research Fund International/American Institute forCancer Research Continuous Update Project Report. Diet, Nutrition, Physical Activity, and Breast Cancer. 2010; Available at: http://www.wcrf.org/sites/default/files/Breast-Cancer-2010-Report.pdf.
92. Gao C, Patel CJ, Michailidou K, et al. on behalf of: the ColorectalTransdisciplinary Study (CORECT); Discovery, Biology and Risk ofInherited Variants in Breast Cancer (DRIVE); Elucidating Loci Involvedin Prostate Cancer Susceptibility (ELLIPSE); Follow-up of OvarianCancer Genetic Association and Interaction Studies (FOCI); andTransdisciplinary Research in Cancer of the Lung (TRICL). Mendelianrandomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. Int J Epidemiol2016;45:896-908. doi:10.1093/ije/dyw129.
93. Guo Y, Warren Andersen S, Shu XO, et al. Genetically Predicted BodyMass Index and Breast Cancer Risk: Mendelian RandomizationAnalyses of Data from 145, 000 Women of European Descent. PLoS Med 2016;13:e1002105. doi:10.1371/journal.pmed.1002105.
94. Baer HJ, Tworoger SS, Hankinson SE, Willett WC. Body fatness at youngages and risk of breast cancer throughout life. Am J Epidemiol2010;171:1183-94. doi:10.1093/aje/kwq045.
95. Baer HJ, Colditz GA, Rosner B, et al. Body fatness during childhoodand adolescence and incidence of breast cancer in premenopausalwomen: a prospective cohort study. Breast Cancer Res 2005;7:R314-25. doi:10.1186/bcr998.
96. Sandholt CH, Allin KH, Toft U, et al. The effect of GWAS identified BMIloci on changes in body weight among middle-aged Danes during afive-year period. Obesity (Silver Spring) 2014;22:901-8. doi:10.1002/oby.20540.
97. Ritte R, Lukanova A, Berrino F, et al. Adiposity, hormone replacementtherapy use and breast cancer risk by age and hormone receptorstatus: a large prospective cohort study. Breast Cancer Res2012;14:R76. doi:10.1186/bcr3186.
98. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M.Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancerrisk: systematic review and meta-regression analysis. Lancet2004;363:1346-53. doi:10.1016/S0140-6736(04)16044-3.
99. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, andendometrial cancer risk: a synthetic review. Cancer EpidemiolBiomarkers Prev 2002;11:1531-43.
100. Geer EB, Shen W. Gender differences in insulin resistance, bodycomposition, and energy balance. Gend Med 2009;6(Suppl 1):60-75.doi:10.1016/j.genm.2009.02.002.
101. Murphy N, Strickler HD, Stanczyk FZ, et al. A Prospective Evaluation ofEndogenous Sex Hormone Levels and Colorectal Cancer Risk inPostmenopausal Women. J Natl Cancer Inst 2015;107: 210.doi:10.1093/jnci/djv210.
102. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Women'sHealth Initiative Investigators. Estrogen plus progestin and colorectalcancer in postmenopausal women. N Engl J Med 2004;350:991-1004.doi:10.1056/NEJMoa032071.
103. Thrift AP, Gong J, Peters U, et al. Mendelian Randomization Study of BodyMass Index and Colorectal Cancer Risk. Cancer Epidemiol BiomarkersPrev 2015;24:1024-31. doi:10.1158/1055-9965.EPI-14-1309.
104. World Cancer Research Fund International/American Institute forCancer Research CUPR. Diet, Nutrition, Physical Activity, andOesophageal Cancer. 2016; Available at: http://www.wcrf.org/sites/default/files/Oesophageal-Cancer-2016-Report.pdf.
105. Thrift AP, Shaheen NJ, Gammon MD, et al. Obesity and risk ofesophageal adenocarcinoma and Barrett's esophagus: a Mendelianrandomization study. J Natl Cancer Inst 2014;106: 252.doi:10.1093/jnci/dju252.
106. Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study oftobacco, alcohol, and the risk of esophageal and gastric cancersubtypes. Am J Epidemiol 2007;165:1424-33. doi:10.1093/aje/kwm051.
107. World Cancer Research Fund International/American Institute forCancer Research. Food, Nutrition, Physical Activity, and the Preventionof Cancer: A Global Perspective.AICR, 2007.
108. Carreras-Torres R, Haycock PC, Relton CL, et al. The causal relevance ofbody mass index in different histological types of lung cancer: AMendelian randomization study. Sci Rep 2016;6:31121. doi:10.1038/srep31121.